Abstract
The metabolism of AA-containing phosphoglycerides within T cell membranes leads to the generation of second messengers that appear to play a crucial role in transmembrane signal transduction. To test the hypothesis that aberrations in the movement of arachidonoyl-phospholipids are associated with and may potentially contribute to abnormal T cell function, the incorporation, distribution, and turnover of AA within the membrane glycerolipids of cells that are known to exhibit immunoregulatory disturbances was examined. Thy-1+, Ly-1+, L3T4-, Lyt-2-, B220+ T cells from autoimmune MRL-lpr/lpr mice were used as the cellular model. In contrast to control lymph node T cells, which preferentially incorporate labeled AA into phosphatidylcholine (PC), B220+ T cells displayed a predilection for distributing [3H]arachidonate into phosphatidylinositol (PI). The arachidonoyl-phospholipid pools were normal in B220+ T cells. The constitutive turnover of [3H]arachidonoyl-PI was significantly enhanced and that of [3H]arachidonate-PC substantially reduced in B220+ T cell compared with control cells. Using membrane homogenates B220+ T cells demonstrated a functional increase in the levels of lyso-PI. Intact B220+ T cells prelabeled with [3H]myoinos...Continue Reading
References
May 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·W T ShierN M Thanassi
Jun 1, 1979·The Journal of Experimental Medicine·C W ParkerM G Huber
May 5, 1989·Science·S G RheeS Y Lee
Jan 1, 1986·Springer Seminars in Immunopathology·A N TheofilopoulosF J Dixon
Feb 13, 1986·Biochemical and Biophysical Research Communications·V G Mahadevappa, B J Holub
Aug 1, 1987·European Journal of Immunology·T J SantoroB L Kotzin
Jun 15, 1987·Biochemical and Biophysical Research Communications·K SekiguchiY Nishizuka
Feb 8, 1985·Biochimica Et Biophysica Acta·A S TaylorJ H Russell
Oct 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·J W HaddenN D Goldberg
Feb 14, 1973·Biochimica Et Biophysica Acta·E Ferber, K Resch
Oct 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·P OverathW Stoffel
Nov 22, 1984·Nature·M J Berridge, R F Irvine
Oct 2, 1980·The New England Journal of Medicine·E J Goetzl
Sep 1, 1981·The Journal of Experimental Medicine·A AltmanF J Dixon
Jul 1, 1983·European Journal of Immunology·T J SantoroA D Steinberg
Nov 1, 1981·The Journal of Experimental Medicine·D WofsyN Talal
Citations
Jan 1, 1994·Life Sciences·K V HackshawY Shi
Sep 3, 2005·Autoimmunity Reviews·Masami TakeiShigemasa Sawada
Dec 1, 1990·The Journal of Experimental Medicine·J D MountzH Blüthmann
Feb 3, 2004·Lipids in Health and Disease·Michiyo TomitaThomas J Santoro
Dec 14, 2011·PloS One·Antonio Catalá-RabasaAntonio Alcina
Oct 8, 1999·Pharmacology & Therapeutics·N B Blatt, G D Glick
Feb 1, 1997·International Journal of Immunopharmacology·M MiharaY Takeda
Oct 1, 1994·International Journal of Immunopharmacology·N N ZhouK Nomoto
Jul 1, 1993·International Journal of Immunopharmacology·S NakaiK Nomoto
Jan 1, 1996·Autoimmunity·J M DuanM P Madaio
Aug 23, 2011·Prostaglandins & Other Lipid Mediators·Karen WagnerBruce D Hammock
Oct 1, 1991·Biochemical Medicine and Metabolic Biology·P J BenkeP Belmar
Aug 1, 1992·Cellular Immunology·S T FurlongH G Remold
Jan 2, 2013·European Journal of Pharmacology·Karen WagnerBruce D Hammock
Dec 1, 1991·European Journal of Immunology·K Yokoyama, G Gachelin
Apr 30, 1993·Biochimica Et Biophysica Acta·S AndoT J Santoro